News
French drugmaker Sanofi said Monday it has agreed to acquire Blueprint Medicines for $9.5 billion, sending shares of the ...
Workers at biotech and pharma companies can command big ... Read next BI Tech Memo An icon in the shape of an angle pointing down.
Hosted on MSN2mon
Funding drought: how can biotech and biopharma keep trials running?It’s widely known in the industry that private investment in biotech and biopharma has been down in recent years. Whilst there was an uptick in biotech and biopharma funding in 2024, this was ...
SB-01 is a 7-amino acid synthetic peptide that binds to and antagonizes TGF-Beta activity. TGF-Beta is a pleiotropic cytokine expressed by almost every tissue and cell type, is stored in abundance ...
while pharma (pharmaceutical) companies develop drugs from chemicals. Image source: Getty Images. There are even different regulatory paths for biotech and pharma products in the U.S. Companies ...
Special Counsel Says ICON CEO Steve Cutler says trial activity has been “impacted by cautious spending from biopharma customers in both the biotech and large pharma businesses.” The company ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results